ArticleCancer biology & medicine2019

TNFα inhibitor C87 sensitizes EGFRvIII transfected glioblastoma cells to gefitinib by a concurrent blockade of TNFα signaling.

Li Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.